A phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

Lance C. Pagliaro, Ebrahim S. Delpassand, Dallas Williams, Randall E. Millikan, Shi Ming Tu, Christopher J. Logothetis

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases'. Together they form a unique fingerprint.

Medicine & Life Sciences